本页面由Tiger Trade Technology Pte. Ltd.提供服务

Lyra Therapeutics

4.01
+0.28007.51%
盘后4.100.0885+2.21%19:31 EST
成交量:11.85万
成交额:45.77万
市值:711.73万
市盈率:-0.14
高:4.32
开:3.62
低:3.47
收:3.73
52周最高:37.50
52周最低:2.84
股本:177.49万
流通股本:132.37万
量比:0.47
换手率:8.95%
股息:- -
股息率:- -
每股收益(TTM):-29.4017
每股收益(LYR):-71.7474
净资产收益率:-404.48%
总资产收益率:-33.08%
市净率:-1.64
市盈率(LYR):-0.06

数据加载中...

2025/03/13

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/13

重要事件披露

Form 8-K - Current report
2025/03/13

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/10

重要事件披露

Form 8-K - Current report
2024/12/16

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/13

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/08/15

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/15

重要事件披露

Form 8-K - Current report
2024/07/23

重要事件披露

Form 8-K - Current report
2024/06/19

重要事件披露

Form 8-K - Current report
2024/06/07

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/05/21

重要事件披露

Form 8-K - Current report
2024/04/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]